GAM
IONS icon

Groupama Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

Groupama Asset Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$61.9M Buy
824,540
+57,651
+8% +$4.55M 0.9% 33
2025
Q4 		$60.7M Buy
766,889
+205,112
+37% +$15.4M 0.89% 29
2025
Q3 		$37.4M Sell
561,777
-99,180
-15% -$4.84M 0.55% 42
2025
Q2 		$26.8M Buy
660,957
+91,746
+16% +$3M 0.44% 49
2025
Q1 		$18.2M Buy
569,211
+52,020
+10% +$1.7M 0.36% 58
2024
Q4 		$18.6M Buy
517,191
+101,131
+24% +$3.78M 0.38% 56
2024
Q3 		$13.8M Buy
416,060
+36,084
+9% +$1.68M 0.36% 57
2024
Q2 		$18.1M Buy
379,976
+122,108
+47% +$5.01M 0.25% 72
2024
Q1 		$17M Sell
257,868
-99,168
-28% -$4.73M 0.31% 67
2023
Q4 		$18.1M Buy
+357,036
New +$17.1M 0.47% 46

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return